| BMY |
Bristol-Myers Squibb Company |
0 |
8.87% |
|
|
|
|
|
N/A |
0.00% |
32.35% |
30.37% |
|---|
| PFE |
Pfizer Inc. |
0 |
7.20% |
|
|
|
|
|
N/A |
0.00% |
29.70% |
22.81% |
|---|
| ABBV |
AbbVie Inc. |
0 |
7.09% |
|
|
|
|
|
N/A |
0.00% |
28.92% |
35.40% |
|---|
| JNJ |
Johnson & Johnson |
0 |
6.83% |
|
|
|
|
|
N/A |
0.00% |
22.69% |
33.81% |
|---|
| MRK |
Merck & Co., Inc. |
0 |
6.56% |
|
|
|
|
|
N/A |
0.00% |
37.20% |
48.24% |
|---|
| GILD |
Gilead Sciences, Inc. |
0 |
4.60% |
|
|
|
|
|
N/A |
0.00% |
44.17% |
72.09% |
|---|
| CAH |
Cardinal Health, Inc. |
0 |
4.13% |
|
|
|
|
|
N/A |
0.00% |
24.26% |
28.15% |
|---|
| VTRS |
Viatris Inc. |
0 |
4.05% |
|
|
|
|
|
N/A |
0.00% |
30.87% |
31.90% |
|---|
| UTHR |
United Therapeutics Corporation |
0 |
3.75% |
|
|
|
|
|
N/A |
0.00% |
35.09% |
56.98% |
|---|
| JAZZ |
Jazz Pharmaceuticals plc |
0 |
3.56% |
|
|
|
|
|
N/A |
0.00% |
31.17% |
71.00% |
|---|
| ZTS |
Zoetis Inc. |
0 |
3.49% |
|
|
|
|
|
N/A |
0.00% |
29.70% |
28.99% |
|---|
| LLY |
Eli Lilly and Company |
0 |
3.19% |
|
|
|
|
|
N/A |
0.00% |
43.04% |
42.62% |
|---|
| AMGN |
Amgen Inc. |
0 |
3.07% |
|
|
|
|
|
N/A |
0.00% |
33.11% |
38.93% |
|---|
| BIIB |
Biogen Inc. |
0 |
2.90% |
|
|
|
|
|
N/A |
0.00% |
37.05% |
38.49% |
|---|
| OGN |
Organon & Co. |
0 |
2.42% |
|
|
|
|
|
N/A |
0.00% |
45.12% |
85.29% |
|---|
| CRL |
Charles River Laboratories International... |
0 |
2.40% |
|
|
|
|
|
N/A |
0.00% |
44.67% |
25.50% |
|---|
| REGN |
Regeneron Pharmaceuticals, Inc. |
0 |
2.34% |
|
|
|
|
|
N/A |
0.00% |
39.66% |
53.19% |
|---|
| MEDP |
Medpace Holdings, Inc. |
0 |
1.86% |
|
|
|
|
|
N/A |
0.00% |
56.20% |
28.01% |
|---|
| NBIX |
Neurocrine Biosciences, Inc. |
0 |
1.61% |
|
|
|
|
|
N/A |
0.00% |
34.71% |
23.57% |
|---|
| ELAN |
Elanco Animal Health Incorporated |
0 |
1.60% |
|
|
|
|
|
N/A |
0.00% |
53.28% |
22.35% |
|---|
| ALKS |
Alkermes plc |
0 |
1.13% |
|
|
|
|
|
N/A |
0.00% |
55.46% |
49.24% |
|---|
| EXEL |
Exelixis, Inc. |
0 |
1.12% |
|
|
|
|
|
N/A |
0.00% |
35.76% |
33.72% |
|---|
| HALO |
Halozyme Therapeutics, Inc. |
0 |
1.10% |
|
|
|
|
|
N/A |
0.00% |
37.56% |
28.31% |
|---|
| PBH |
Prestige Consumer Healthcare Inc. |
0 |
0.95% |
|
|
|
|
|
N/A |
0.00% |
28.23% |
28.43% |
|---|
| PRGO |
Perrigo Company plc |
0 |
0.95% |
|
|
|
|
|
N/A |
0.00% |
43.05% |
18.61% |
|---|
| CORT |
Corcept Therapeutics Incorporated |
0 |
0.79% |
|
|
|
|
|
N/A |
0.00% |
65.42% |
63.56% |
|---|
| TGTX |
TG Therapeutics, Inc. |
0 |
0.74% |
|
|
|
|
|
N/A |
0.00% |
56.82% |
38.31% |
|---|
| PTGX |
Protagonist Therapeutics, Inc. |
0 |
0.69% |
|
|
|
|
|
N/A |
0.00% |
68.70% |
7.40% |
|---|
| ACLX |
Arcellx, Inc. |
0 |
0.63% |
|
|
|
|
|
N/A |
0.00% |
46.12% |
47.43% |
|---|
| ITCI |
Intra-Cellular Therapies, Inc. |
|
0.63% |
|
|
|
|
|
|
|
|
|
|---|
| ALNY |
Alnylam Pharmaceuticals, Inc. |
0 |
0.62% |
|
|
|
|
|
N/A |
0.00% |
41.52% |
13.06% |
|---|
| TWST |
Twist Bioscience Corporation |
0 |
0.60% |
|
|
|
|
|
N/A |
0.00% |
66.71% |
19.60% |
|---|
| VCEL |
Vericel Corporation |
0 |
0.59% |
|
|
|
|
|
N/A |
0.00% |
58.27% |
59.56% |
|---|
| INCY |
Incyte Corporation |
0 |
0.57% |
|
|
|
|
|
N/A |
0.00% |
42.37% |
39.01% |
|---|
| ADMA |
ADMA Biologics, Inc. |
0 |
0.55% |
|
|
|
|
|
N/A |
0.00% |
61.47% |
9.90% |
|---|
| ACAD |
ACADIA Pharmaceuticals Inc. |
0 |
0.55% |
|
|
|
|
|
N/A |
0.00% |
52.38% |
39.63% |
|---|
| ROIV |
Roivant Sciences Ltd. |
0 |
0.51% |
|
|
|
|
|
N/A |
0.00% |
32.36% |
54.06% |
|---|
| EXAS |
Exact Sciences Corporation |
0 |
0.50% |
|
|
|
|
|
N/A |
0.00% |
45.25% |
33.12% |
|---|
| BPMC |
Blueprint Medicines Corporation |
0 |
0.50% |
|
|
|
|
|
N/A |
0.00% |
66.68% |
19.74% |
|---|
| AMRX |
Amneal Pharmaceuticals, Inc. |
0 |
0.50% |
|
|
|
|
|
N/A |
0.00% |
67.35% |
39.78% |
|---|
| INSM |
Insmed Incorporated |
0 |
0.49% |
|
|
|
|
|
N/A |
0.00% |
46.27% |
20.44% |
|---|
| SRPT |
Sarepta Therapeutics, Inc. |
0 |
0.49% |
|
|
|
|
|
N/A |
0.00% |
81.57% |
48.46% |
|---|
| KRYS |
Krystal Biotech, Inc. |
0 |
0.45% |
|
|
|
|
|
N/A |
0.00% |
46.99% |
22.87% |
|---|
| KYMR |
Kymera Therapeutics, Inc. |
0 |
0.45% |
|
|
|
|
|
N/A |
0.00% |
67.60% |
61.13% |
|---|
| BMRN |
BioMarin Pharmaceutical Inc. |
0 |
0.44% |
|
|
|
|
|
N/A |
0.00% |
33.04% |
36.60% |
|---|
| VRTX |
Vertex Pharmaceuticals Incorporated |
0 |
0.44% |
|
|
|
|
|
N/A |
0.00% |
29.88% |
28.22% |
|---|
| IONS |
Ionis Pharmaceuticals, Inc. |
0 |
0.40% |
|
|
|
|
|
N/A |
0.00% |
57.02% |
24.72% |
|---|
| RNA |
Avidity Biosciences, Inc. |
0 |
0.36% |
|
|
|
|
|
N/A |
0.00% |
67.15% |
60.52% |
|---|
| VKTX |
Viking Therapeutics, Inc. |
0 |
0.34% |
|
|
|
|
|
N/A |
0.00% |
77.96% |
31.22% |
|---|
| MYGN |
Myriad Genetics, Inc. |
0 |
0.26% |
|
|
|
|
|
N/A |
0.00% |
60.35% |
64.76% |
|---|
|
US Dollar |
|
0.13% |
|
|
|
|
|
|
|
|
|
|---|